Novavax | NVAX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Adma Biologics USD 2.15B 2.19B 2026-03
Agenus USD 3.19B 3.06B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Cassava Sciences USD 82M 14M 2026-03
Geron USD 979M 24M 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
MannKind USD 1.11B 207M 2026-08
Merck USD 324.18B 6.81B 2026-08
Novartis USD 288.26B 25.18B 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.17B 14.73B 2026-08
Sanofi EUR 91.15B 9.12B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
TG Therapeutics USD 7.63B 778M 2026-08